279 related articles for article (PubMed ID: 2457256)
1. Biologic response modifiers in the therapy of metastatic renal cell carcinoma.
Quesada JR
Semin Oncol; 1988 Aug; 15(4):396-407. PubMed ID: 2457256
[No Abstract] [Full Text] [Related]
2. Immunotherapeutic approaches for renal cancer.
Pizza G; de Vinci C; Viza D
Folia Biol (Praha); 2002; 48(5):167-81. PubMed ID: 12448765
[No Abstract] [Full Text] [Related]
3. [The immunotherapy of advanced renal cell carcinoma].
Bergmann L; Weidmann E; Mitrou PS
Dtsch Med Wochenschr; 1991 Mar; 116(10):384-90. PubMed ID: 1705879
[No Abstract] [Full Text] [Related]
4. Interferons and interleukins in metastatic renal cell carcinoma.
Choudhury M; Efros M; Mittelman A
Urology; 1993 Jan; 41(1 Suppl):67-72. PubMed ID: 7678365
[TBL] [Abstract][Full Text] [Related]
5. Renal cell cancer: is immunotherapy dead?
Wagstaff J
Ann Oncol; 2007 Jul; 18 Suppl 9():ix94-7. PubMed ID: 17631604
[No Abstract] [Full Text] [Related]
6. [Immunotherapy of metastatic renal cell cancer].
Manseck A; Wirth M
Urologe A; 1993 Sep; 32(5):360-73. PubMed ID: 7692655
[TBL] [Abstract][Full Text] [Related]
7. Adoptive cellular therapy.
Hoffman DM; Gitlitz BJ; Belldegrun A; Figlin RA
Semin Oncol; 2000 Apr; 27(2):221-33. PubMed ID: 10768601
[TBL] [Abstract][Full Text] [Related]
8. Renal cell carcinoma and interleukin-2: a review.
Wagstaff J; Baars JW; Wolbink GJ; Hoekman K; Eerenberg-Belmer AJ; Hack CE
Eur J Cancer; 1995; 31A(3):401-8. PubMed ID: 7540404
[No Abstract] [Full Text] [Related]
9. [Biologic response modifiers in the treatment of solid tumors].
Tagliaferri F; Lucandri G; Stipa F; Stipa S
Recenti Prog Med; 1991 Jun; 82(6):352-8. PubMed ID: 1718019
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for renal cell carcinoma.
Rosenblatt J; McDermott DF
Hematol Oncol Clin North Am; 2011 Aug; 25(4):793-812. PubMed ID: 21763968
[TBL] [Abstract][Full Text] [Related]
11. Emerging immunotherapy in advanced renal cell carcinoma.
Mendiratta P; Rini BI; Ornstein MC
Urol Oncol; 2017 Dec; 35(12):687-693. PubMed ID: 28889919
[TBL] [Abstract][Full Text] [Related]
12. The role of interferon and interleukin-2 in the immunotherapeutic approach to renal cell carcinoma.
Figlin RA; Abi-Aad AS; Belldegrun A; deKernion JB
Semin Oncol; 1991 Oct; 18(5 Suppl 7):102-7. PubMed ID: 1719641
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for metastatic renal cell carcinoma.
Wirth MP
Urol Clin North Am; 1993 May; 20(2):283-95. PubMed ID: 7684167
[TBL] [Abstract][Full Text] [Related]
14. Systemic therapy of metastatic renal cell carcinoma.
Vugrin D
Semin Nephrol; 1987 Jun; 7(2):152-62. PubMed ID: 2442806
[No Abstract] [Full Text] [Related]
15. Biological therapy for metastatic renal cell cancer.
Lancet; 1991 Mar; 337(8740):522-3. PubMed ID: 1705643
[No Abstract] [Full Text] [Related]
16. Novel investigative approaches for advanced renal cell carcinoma.
Berg WJ; Divgi CR; Nanus DM; Motzer RJ
Semin Oncol; 2000 Apr; 27(2):234-9. PubMed ID: 10768602
[TBL] [Abstract][Full Text] [Related]
17. Metastatic renal-cell carcinoma: what causes occasional dramatic regressions?
Young RC
N Engl J Med; 1998 Apr; 338(18):1305-6. PubMed ID: 9562587
[No Abstract] [Full Text] [Related]
18. Immune status and immune therapy of renal cell carcinoma.
Bichler KH; Kleinknecht S; Strohmaier WL
Urol Int; 1990; 45(5):269-83. PubMed ID: 2219564
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of renal cell carcinoma.
Haas GP; Hillman GG; Redman BG; Pontes JE
CA Cancer J Clin; 1993; 43(3):177-87. PubMed ID: 8490757
[TBL] [Abstract][Full Text] [Related]
20. The role of cytokines in the therapy of renal cell carcinoma.
Ebert T; Schmitz-Dräger BJ; Ackermann R
Recent Results Cancer Res; 1993; 126():113-8. PubMed ID: 7681213
[No Abstract] [Full Text] [Related]
[Next] [New Search]
